Pfizer projects 2025 revenue growth up to $64 billion
Pfizer Inc. (NYSE:PFE) has issued its financial guidance for the full year 2025, projecting revenue growth between $61 billion and $64 billion, representing a flat...
Tag : Ozempic
New study highlights potential of Pfizer’s oral weight loss drug as alternative to Ozempic
A peer-reviewed study released on Monday reveals that an oral weight loss drug developed by Pfizer demonstrates similar efficacy and faster results compared to Novo...